Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00580424
What this trial is testing

The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots

Who this might be right for
Women's HealthBlood Coagulation Disorders
University of Vermont 20
Not applicableLooking for participantsNCT06168370
What this trial is testing

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation

Who this might be right for
Severe Aortic Valve Stenosis
St. Antonius Hospital 2,500
Not applicableUnknownNCT04115436
What this trial is testing

Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation

Who this might be right for
Thromboembolic Events
Texas Cardiac Arrhythmia Research Foundation 40
Not applicableStudy completedNCT04414332
What this trial is testing

Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry

Who this might be right for
Venous Thromboembolic DiseaseDeep Venous ThrombosisRight Heart Pathology+1 more
University of California, Los Angeles 234
Not applicableUnknownNCT06003244
What this trial is testing

High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)

Who this might be right for
Pulmonary Vascular DiseasePulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension
University of Zurich 24
Not applicableUnknownNCT02877251
What this trial is testing

Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease

Who this might be right for
Venous ThromboembolismVenous ThrombosisPulmonary Embolism
Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa 500
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)Study completedNCT03409588
What this trial is testing

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty

Who this might be right for
Chronic Thromboembolic Disease (CTED)Exercise Intolerance Post PEA Surgery
University of Colorado, Denver 10
Testing effectiveness (Phase 2)UnknownNCT05189002
What this trial is testing

Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement

Who this might be right for
Venous Thromboembolism
PharmaDiall Ltd. 240
Not applicableUnknownNCT00400504
What this trial is testing

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Who this might be right for
Cancer
Rigshospitalet, Denmark 500
Large-scale testing (Phase 3)Ended earlyNCT00580216
What this trial is testing

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sanofi 3,773
Not applicableUnknownNCT04052243
What this trial is testing

Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH

Who this might be right for
Chronic Thromboembolic Pulmonary Hypertension
Aarhus University Hospital 80
Not applicableUnknownNCT03887806
What this trial is testing

Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Strasbourg, France 300
Not applicableStudy completedNCT07165587
What this trial is testing

Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)

Who this might be right for
Pelvic FracturesAcetabular FracturesPelvic Trauma+4 more
Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu 81
Not applicableEnded earlyNCT01051297
What this trial is testing

Obstructive Sleep Apnea and Venous Thromboembolism

Who this might be right for
Obstructive Sleep ApneaVenous ThrombosisPulmonary Embolism+1 more
University of Missouri-Columbia 85
Not applicableUnknownNCT01372514
What this trial is testing

Institutional Registry of Thromboembolic Disease

Who this might be right for
ThromboembolismVenous ThromboembolismPulmonary Embolism
Hospital Italiano de Buenos Aires 4,500
Not applicableEnded earlyNCT01938404
What this trial is testing

Octaplas Adult TTP Trial

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Octapharma 1
Not applicableLooking for participantsNCT04628078
What this trial is testing

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Who this might be right for
Atrial FibrillationCardiovascular DiseasesThromboembolism
Insel Gruppe AG, University Hospital Bern 1,000
Large-scale testing (Phase 3)Study completedNCT00244426
What this trial is testing

S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Pfizer 1,372
Large-scale testing (Phase 3)Study completedNCT03395639
What this trial is testing

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Who this might be right for
Cardiac Disease
Daiichi Sankyo 168
Next Page